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For VMAT beams, we have chosen to smooth the IQM signal 
over the segments with a Gaussian filter to account for the 
exact segment timing. Evaluation takes place on the 
maximum difference per segment signal and in the 
cumulative signal, with respect to the clinical beam. 
Additionally, the clinical beams were measured repeatedly to 
take into account machine variations. 
As a comparison, all beams are additionally measured with 
the Delta4 system (Scandidos), which is the standard QA tool 
in our department. Analogously to the IQM measurements, 
the clinical beams are used as references. The differences in 
gamma pass rate (3%/3mm) and the median dose differences 
(DD) are assessed as a measure of agreement between the 
beams. 
To assess the sensitivity and specificity of error detection, a 
receiver-operating characteristic (ROC) curve is created by 
varying the cut-off criterion for error detection. 
Results: In figure 1, the results of the IQM and Delta4 system 
measurements are plotted. The left graph shows the IQM 
results, where it is clearly visible that modified beams 
produce higher differences with respect to the reference 
beams. In the Delta4 measurements (middle graph) this effect 
is less pronounced.  
This is confirmed by the ROC-curve (right upper graph), 
which shows an improved sensitivity and specificity for error 
detection by the IQM system compared to the Delta4 system. 
Conclusions: A first test of the IQM system indicates an 
excellent sensitivity and specificity in error detection during 
beam delivery. Future tests, including beams with smaller 
deviations/errors, will have to show the detection limits of 
the IQM system. 
1) M. Islam et al. An integral quality monitoring system for 
real-time verification of intensity modulated radiation 
therapy. Med Phys 2009, 36(12): 5420-5428 
2) J. Chang et al. A method for online verification of adapted 
fields using an independent dose monitor. Med Phys 2013, 
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Purpose/Objective: As part of a new multinational research 
project, methodology for an audit of MLC performance in 
radiotherapy facilities has been developed and a pilot audit 
conducted. The purpose of this audit was to check the 
performance of an accelerator’s MLC by verifying the 
positional accuracy of the individual MLC leaves using 
radiochromic films. At the same time, the pilot audit tested 
the auditing methodology. Performance of MLCs is 
particularly important for techniques such as IMRT that use 
steep dose gradients and precise dose delivery relies on 
accurate positioning of MLC leaves.  
Materials and Methods: 44 hospitals from 12 countries took 
part in this pilot audit using 17 different linear accelerators 
models and 9 different MLC models. Participants were asked 
to irradiate a five strip ‘picket fence’ pattern on EBT3 film 
and, after irradiation, return the film to the auditing 
laboratory for evaluation. The film was positioned in a solid 
water slab phantom at a 100 cm SAD setup, at a depth of 
dmax. The field edges were defined by the machines’ MLCs 
(with the exception of the central strip for Varian machines, 
which was defined by the secondary jaws). Participants were 
asked to generate a picket fence pattern with a minimum 
achievable width for the strips and deliver 250 MU for each 
strip. Upon their return to the auditing laboratory, the films 
were scanned on an EPSON 11000 scanner and analysed using 
FilmQA Pro software. Opening width and positioning bias for 
each pair of leaves and for each strip were measured. 
Results: The results identify 9 different MLC models (Elekta: 
Agility (2), Beam Modulator(1), MLCi2 (9); Siemens: 
MLC58(2), MLC82(2), MLC160(1); Varian: Millenium 80(8), 
Millenium 120(18), HD120(1)). The agreement within ±0.5 mm 
between the positioning bias of individual pairs of leaves and 
the average of all pairs of leaves was considered satisfactory. 
As can be seen on Figure 1, seven participants had their 
leaves bias exceeding the acceptance criteria. The best 
results for leaves bias were achieved for two collimator 
models: HD 120 and Millenium 120. 
 
 
Figure 1. Minimum, maximum and average positioning bias 
for MLCs included in the pilot audit.  
The agreement of ±0.75 mm between the opening width of 
individual pairs of leaves and the average of all pairs of 
leaves and 0.3 mm standard deviation for opening widths of 
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all leaves was considered satisfactory. This condition was 
fulfilled by 36 of 44 participants. Follow-up of unsatisfactory 
results is on-going. 
 
Conclusions: The pilot audit of MLC performance has proven 
that the methodology for this audit worked well. About 80% 
of participants achieved satisfactory results. The hospitals 
with poor results were alerted of their MLCs sub-optimal 
performance. The positional accuracy of MLCs recorded in 
this audit is indicative of the accuracy relevant to clinical 
IMRT procedures. 
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Purpose/Objective: With regard to the complex dose 
distributions produced by active raster scanning, each 
treatment plan has to be verified before treatment. At the 
Heidelberg Ion-beam Therapy Center (HIT) patient specific 
dose verification is currently performed by using an array of 
24 ionization chambers. Due to the limited sampling period 
(~14 mm) of this system, a high resolution (~0.2 mm) flat 
panel detector has been investigated to supplement these 
dose measurements with fluence measurements in the dose 
plateau area of the depth dose distributions. 
Materials and Methods: A procedure is presented to correct 
the flat panel raw data and convert the corrected data into 
fluence distributions after suitable energy calibration. In the 
present work the fluence measurements have been realized 
using patient relevant accelerator settings. Additionally, a 
state of the art flat panel detector (XRD 0822 without 
scintillator, Perkin Elmer, Germany) was investigated with 
respect to signal quality and mandatory image corrections. 
After each measurement, the generated fluence distributions 
are checked against expected fluence distributions calculated 
from respective beam parameters. Using this method, 
fluence distributions can additionally be checked for each iso 
energy layer. To quantify the agreement between the 
measured and calculated fluence distributions a gamma index 
analysis has been performed. A global gamma index criterion 
of 5 % fluence deviation and 1 mm distance to agreement was 
used. Values below 3 % of the fluence maximum in each iso 
energy layer have not been taken into account.  
Results: Treatment plans with up to 2-3 Gy can be measured 
at the highest available beam intensity without any effects of 
detector signal saturation. So far, 6 proton treatment plans 
and 12 carbon ion treatment plans have been investigated. 
Averaged over all treatment plans, the gamma-index 
criterion was met in more than 98 % of the fluence values for 
protons and more than 96 % for carbon ions.  
Conclusions: A specific protocol was established to process 
flat panel raw data: It contains necessary offset, gain and 
bad pixel corrections, as well as an energy calibration. Based 
on two-dimensional high resolution fluence measurements in 
the dose plateau area of the depth dose distributions it is 
possible to provide supplementary information to 
conventional dose measurements. The corrected and 
calibrated flat panel detector signal shows promising results 
compared to the calculated data. However, before using this 
protocol in clinical routine, further studies, especially 
towards irradiation damage of the detector, have to be 
performed. So far, further bad pixels have not been 
detected.  
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Purpose/Objective: Flattening Filter Free (FFF) radiotherapy 
has recently become widely discussed in particular for 
stereotactic treatments where large doses per fraction (frac.) 
can be delivered quicker due to the higher dose rate. 
However, the original idea of FFF was not mainly to increased 
dose rate, but instead to reduce head scatter and thereby 
scattered dose to the entire patient. The purpose of this 
study was to investigate if normal fractionated treatments 
(1.8 – 2.0 Gy per frac.) could be delivered with clinically 
relevant dose accuracy and if there were any gains in 
treatment delivery because of the higher dose rate, or gains 
in treatment plans from the reduced scatter.  
Materials and Methods: In three of the main radiotherapy 
treatment sites (brain, head and neck (H&N) and lung) the 
first 10 curatively treated patients in 2014, having a single 
target and treated with a single full or half VMAT arc were 
selected. The patients were re-planned on Pinnacle ver. 9.8 
for the Elekta Versa HD linac. The dose prescriptions were 
59.4 Gy in 33 frac. for brain and 66 Gy in 33 frac. for H&N 
and lung. For each patient two plans were created with 
different beams (6 MV and 6 MV FFF). Both plans were 
optimised with the same fixed number of iterations and with 
no change to VMAT objectives. All treatment plans were 
delivered and dose accuracy evaluated using the Sun Nuclear 
ArcCheck phantom and analysed using a 3% and 3 mm global 
gamma between planned and measured doses. Beam on times 
were recorded for treatment beams. All DVH metrics were 
tested for significant differences with a paired two-sided 
Wilcoxon-signed rank test, with a significance level of 5%. 
Results: The mean dose to the body is reduced in the FFF 
treatment plans compared to the FF (Flattening Filter) plans 
for all 3 treatments sites (p=0.05, see table). For brain and 
H&N there are only small differences in target dose, however 
for the lung treatment PTV D2% (near max) and D98% (near 
minimum) the FFF plans are slightly less favourable. For H&N 
the FFF delivery is slower to deliver despite the higher dose 
rate. This might be due to the higher MLC modulation needed 
to compensate for the inhomogeneous profile of the FFF 
beam. The higher MLC modulation effect is seen for all three 
sites in the number of MU needed for the plans (p=0.002). 
The pass rate from the ArcCheck measurements are all 
